Literature DB >> 6336773

Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region.

V A Fischetti.   

Abstract

By two independent techniques for separating human opsonic IgG for group A type 6 streptococci into fast- and slow-migrating fractions, it was found that the opsonic activity was localized within the basic charge population. This charge dependence was found to be a characteristic of the IgG isolated from three individuals. When the fast- and slow-migrating IgG fractions were tested for their ability to bind to purified M6 protein, antibodies in both opsonic and nonopsonic populations exhibited binding activity, with the majority being located within the opsonic IgG in two of the three individuals; the third displayed greater binding in the nonopsonic population. The functional difference observed in the antibody populations to this M antigen may be a reflection of the net charge within the area of the antibody binding site, which suggests that the opsonic antibodies need to bind to acidic residues along the outer surface of the fibrillar M protein molecule. F(ab')2 fragments prepared from both human and rabbit type 6 opsonic IgG were still able to bind to the M6 molecule but were unable to mediate opsonization of type 6 streptococci. However, the F(ab')2 fragments had the capacity to enhance or amplify the opsonic activity of low concentrations of opsonic IgG molecules. The results suggest that the M protein molecule may function as an active inhibitor of phagocytosis and that F(ab')2 fragments from opsonic IgG have the capacity to neutralize the "active" determinants on the molecule, thus allowing lower concentrations of IgG with functional Fc receptors to mediate phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336773

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Primary structure of streptococcal Pep M5 protein: Absence of extensive sequence repeats.

Authors:  B N Manjula; S M Mische; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 2.  Molecular aspects of the phagocytosis resistance of group A streptococci.

Authors:  B N Manjula
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

3.  Isolation and characterization of the cell-associated region of group A streptococcal M6 protein.

Authors:  V Pancholi; V A Fischetti
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

Review 4.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

5.  Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties.

Authors:  B N Manjula; B L Trus; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

6.  Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci.

Authors:  K F Jones; V A Fischetti
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood.

Authors:  J S Boschwitz; J F Timoney
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.

Authors:  K Hong; T Kinoshita; J Takeda; H Kozono; P Pramoonjago; Y U Kim; K Inoue
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

9.  Polyamino acid enhancement of bacterial phagocytosis by human polymorphonuclear leukocytes and peritoneal macrophages.

Authors:  P K Peterson; G Gekker; R Shapiro; M Freiberg; W F Keane
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan.

Authors:  H Fillit; S P Damle; J D Gregory; C Volin; T Poon-King; J Zabriskie
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.